Phase II Pilot Project Awardees and Subsequent Grant Success

Investigator & Dept. Title Grant
Alexei Kisselev, Ph.D.
(NCCC & Pharmacology)
Active Sites of the Immuno-Proteasome as Drug Targets R01
Michael Whitfield, Ph.D.
Scleroderma Subtypes R01, NHIRC
Ruth Connor, Ph.D.
Lactobacilli in Mucosal Defense Against HIV-1 in The Female Reproductive Tract R21/R33, R01
Edward Usherwood, Ph.D.
T cell Function in Murine Gammaherpes Virus Infection R01
Stephanie Dorosko, D.V.M., Ph.D.
Mechanisms for HIV-1 Persistance in Human Mammary Tissue and Breast Milk Cells K08
James Gorham, M.D./Ph.D
Chemokines in Autoimmune Hepatitis R01
Mary Jo Turk, Ph.D.
(Micro/Immuno, NCCC)
Post-excisional Memory T cell Responses to Tumors NHIRC, R43
Ralph Nichols, Ph.D.
Translational Regulation of VEGF Gene Expression VA Merit renewal
Radu Stan,Ph.D.
The Role of PV1 Protein in Immunity R01
Jennifer Bomberger, Ph.D.
Polymicrobial Interactions and Immunity in the Lung Pending K99/R00
Patricia Pioli, Ph.D
Sex Hormone Effects on FRT Macrophage Function  
Javier Ochoa, Ph.D
Gut Commensal Microflora in the Development of EAE  
Michael Zegans, M.D.
Polysorbate 80 mediated biofilm inhibition of Pseudomonas aeruginosa  
Richard Chou, M.D.
Lipid-cytokine-chemokine cascades in inflammatory arthritis